|
US2012082665A1
|
|
Prevention and treatment of pain using antibodies to sphingosine-1-phosphate
|
|
US2012014944A1
|
|
Prevention and treatment of pain using antibodies to lysophosphatidic acid
|
|
US2011064744A1
|
|
Prevention and treatment of pain using antibodies to lysophosphatidic acid
|
|
US2011118443A1
|
|
Antibody design using anti-lipid antibody crystal structures
|
|
US2011076267A1
|
|
Humanized antibody compositions and methods for binding lysophosphatidic acid
|
|
US2010292443A1
|
|
Humanized platelet activating factor antibody design using anti-lipid antibody templates
|
|
US2010098700A1
|
|
Pharmaceutical compositions for binding sphingosine-1-phosphate
|
|
US2010034814A1
|
|
Compositions and methods for binding lysophosphatidic acid
|
|
US2009074720A1
|
|
Methods for decreasing immune response and treating immune conditions
|
|
US2008213274A1
|
|
Compositions and methods for the treatment and prevention of fibrotic, inflammatory, and neovascularization conditions of the eye
|
|
US2008138334A1
|
|
Immune-Derived Moieties Reactive Against Bioactive Lipids, and Methods of Making and Using Same
|
|
US2007281320A1
|
|
Bioactive lipid derivatives, and methods of making and using same
|
|
US2008090303A1
|
|
Methods and reagents for detecting bioactive lipids
|
